Overview
To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with COPD
Description
The purpose of this study is to evaluate the safety and effectiveness of human umbilical cord mesenchymal stem cells in 40 patients with COPD at Vinmec International Hospital, Hanoi, Vietnam
Eligibility
Inclusion Criteria:
- Age over 40
- Patients with COPD stage B, C or D according to GOLD 2019
- Agree to join the clinical trial and sign patient consent.
Exclusion Criteria:
- Patients with acute infection, cancer, cardiovascular disease, liver failure, severe renal failure.
- Patients with other lung diseases not COPD.
- Pregnant or lactating.
- Life expectancy < 6 months due to concomitant illnesses.
- Being treated immunosuppressive drugs oral or intravenous.
- Patients with type II diabetes with HbA1C over 7%
- Currently smoking or quit smoking less than 3 months.
- Any medical condition, which in the opinion of the clinical investigator, would interfere with the treatment or outcome of the patients.